Intracardiac giant cells after left ventricular assist device placement

Hubert Fenton1, Daniel P Judge, David D Yuh

  • 1Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.

Insights

Solitary giant cells in the heart after left ventricular assist device (LVAD) implantation and Candida glabrata infection are reported. This finding is distinct from severe giant cell myocarditis, preventing misdiagnosis in heart transplant patients.

Area of Science:

  • Cardiovascular Pathology
  • Transplant Pathology
  • Infectious Disease Pathology

Background:

  • Multinucleated giant cells in cardiac tissue are associated with conditions like giant cell myocarditis, sarcoidosis, and infections.
  • Left ventricular assist devices (LVADs) are used to treat advanced heart failure.

Observation:

  • The study reports the first instance of solitary multinucleated giant cells observed in the heart following LVAD placement.
  • These findings were identified in an explanted heart 7 months after LVAD surgery, during orthotopic cardiac transplantation.
  • A transient Candida glabrata infection was also noted in the patient's history.

Findings:

  • The key histologic finding was the presence of scattered, solitary giant cells without accompanying inflammation.
  • This pattern is distinct from more aggressive giant cell-related cardiac pathologies.

Implications:

  • Recognizing this specific pattern of giant cells is crucial for accurate diagnosis.
  • Avoiding misdiagnosis prevents unnecessary concern for recurrent severe cardiac disease in transplanted hearts.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...